This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Latest Weight-Loss Craze... Combo-Pilling

"The most popular Combo-Pilling duo seems to be Relacore®, called 'America's #1 Belly Fat Pill,' and Zantrex®-3, the high-energy diet pill that's been a consumer favorite for years," says Chantelle Daines, a Majestic Media analyst. "People are making claims of huge weight-loss success when they Combo-Pill with these two, possibly because Relacore helps address problematic nervous binge eating and stress-related belly fat, while Zantrex was formulated for rapid weight loss and an incredible burst of energy."

Both Relacore and Zantrex are readily available at WalMart, Walgreens, CVS, Rite Aid, and smarter retailers nationwide. It's a bit more difficult to find them online because you have to go to two separate websites. You can find Zantrex at and Relacore at

For some, using a supplement that offers dual weight-loss products in one easy package is more appealing. The most powerful in this category is called BiphedAdrene®, the Super Powerful "Diet Pill" that's been flying off store shelves. Biphed's maker revealed to Ms. Daines that BiphedAdrene is a two-part system comprised of a unique "Complex Phenylethylamine Provisional" (for powerful appetite control, mood-elevation, and energy) — the "Purple Pill" — combined with an aggressive thermogenic compound (for fat burning and stamina) — the "Yellow Pill." This two-pronged attack on fat is apparently what makes this "Combo-Pilling" superstar so effective... and so popular. BiphedAdrene is available exclusively at GNC or direct from the manufacturer at A 30-day supply costs $135, but if you use promo code COMBO at the manufacturer's website you get $25 off and free shipping.

And it's not just the dietary supplement industry that's returning to Combo-Pilling. The U.S. FDA has just approved Qsymia (formerly Qnexa). It's a combo of phentermine, an appetite suppressant that was half of the Fen-Phen diet pill, and topiramate, which was originally designed as a drug to treat epilepsy and seizures. Because it's a drug, not a dietary supplement, you need to visit your doctor and get a prescription if you're interested in trying this Combo-Pill.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs